A new study presented at the European Society of Cardiology's EHRA 2025 congress reveals a concerning link between the use of antidepressants (AD) and an increased risk of sudden cardiac death (SCD), particularly for those with prolonged use of the medication.
Antidepressants, such as Prozac, are routinely used to treat mental health issues, but recent research reveals they may also protect against major infections and life-threatening sepsis. Scientists at the Salk Institute have now discovered how medications regulate the immune system and prote
Glioblastoma is an extremely aggressive brain tumour that is currently incurable. Cancer doctors can increase their patients' life expectancy with surgeries, radiation, chemotherapy, or surgical procedures. Nonetheless, half of patients die within a year of diagnosis.
Mumbai (Maharashtra) [India], August 12: Atul Bioscience Ltd (ABL), a 100 per cent subsidiary company of Atul Ltd, received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its manufacturing facility situated in Ambernath, Maharashtra.
Major depressive disorder (MDD) is a common mental illness that is incapacitating for many people. It has long been understood that MDD is influenced by both environmental and genetic factors.
Researchers at Stanford Medicine have described a novel subtype of depression known as the cognitive biotype, which affects 27 per cent of people with depression but is unresponsive to treatment with antidepressants that are frequently administered.
Depression affects millions of people globally as a result of psychological stress. Most antidepressant drugs, on the other hand, are slow, prone to resistance, and have severe side effects, prompting the creation of more effective therapeutic options.
It has been proven safe and effective in numerous clinical trials involving patients whose MDD does not respond to antidepressant medication. Conventionally, rTMS is given once daily 20 to 30 days over four to six weeks. That places great time demands on both patients and clinicians.
Millions of individuals worldwide suffer from depression as a result of psychological stress. However, most antidepressant medications are sluggish, prone to resistance, and have severe side effects, necessitating the development of more effective therapy alternatives.
A recent study published in Neuropsychopharmacology by experts from the Universities of Helsinki and Eastern Finland offers insight into the brain plasticity processes generated by the antidepressant fluoxetine.
An international team of researchers, including academics from the University of Warwick, has found that some classes of antidepressants were effective in treating certain pain conditions in adults, but others were either not effective, or the effectiveness was unknown